Table 2.
Summary of LEfSe analysis results.
| Biological factors | Datasets | Differential genus | |||
|---|---|---|---|---|---|
| Tumor high grade | PRJNA534108 | Mycolicibacterium33 | ↑ | Paenibacillus37 | ↓ |
| Pasteurella26 | ↓ | ||||
| Brevibacillus38 | ↓ | ||||
| Rothia39 | ↓ | ||||
| Pseudomonas13 | ↓ | ||||
| Porphyrobacter16 | ↓ | ||||
| Tumor tissue source | PRJNA552055 | Pasteurella26 | ↑ | Mycolicibacterium33 | ↓ |
| Porphyrobacter16 | ↑ | ||||
| Streptomyces27 | ↑ | ||||
| Pseudomonas13 | ↑ | ||||
| PRJNA186504 | Psychrobacillus40 | ↑ | Chlamydia23 | ↓ | |
| Rhodoplanes41 | ↑ | Bartonella21 | ↓ | ||
| Pseudolabrys42 | ↑ | Rummeliibacillus43 | ↓ | ||
| Lysobacter44 | ↑ | Micrococcus45 | ↓ | ||
| Comamonas46 | ↑ | Paenibacillus37 | ↓ | ||
| Desulfarculus47 | ↑ | Bosea48 | ↓ | ||
| Streptomonospora49 | ↑ | Oligotropha50 | ↓ | ||
| Acinetobacter5 | ↑ | Afipia51 | ↓ | ||
| Mycoplasma52 | ↑ | Erythrobacter53 | ↓ | ||
| Delftia54 | ↑ | Alicycliphilus55 | ↓ | ||
| Pseudomonas13 | ↑ | Brevibacillus38 | ↓ | ||
| Methylorubrum56 | ↑ | ||||
| Chryseobacterium46 | ↑ | ||||
| BCG therapy by the response to durable | PRJNA735225 | Erythrobacter53 | ↑ | Pasteurella26 | ↓ |
| Corynebacterium5 | ↑ | Simkania57 | ↓ | ||
| Streptomyces27 | ↑ | ||||
| Mycolicibacterium33 | ↑ | ||||
| MPBC tissue | PRJNA562495 | Pasteurella26 | ↑ | Halomonas19 | ↓ |
| Porphyrobacter16 | ↑ | Mycolicibacterium33 | ↓ | ||
| Streptomyces27 | ↑ | Ralstonia | ↓ | ||
| Enterobacter58 | ↓ | ||||
| Bacillus5 | ↓ | ||||
| Staphylococcus59 | ↓ | ||||
| Kosakonia60 | ↓ | ||||
The arrows indicate the up-regulation or down-regulation of this genus in this biological factor and studies correlating the genus with tumor or disease development are cited.